Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Inverness offers rapid detection of C difficile infection in a matter of minutes

Inverness Medical Innovations : 07 July, 2008  (New Product)
Inverness Medical provides rapid detection of C difficile infection in under 30 minutes with the Techlab C. Diff Quik Chek for the detection of C difficile antigen glutamate dehydrogenase (GDH) which is common to all strains of C difficile and Techlab Tox A/B Quik Chek for detection of Toxins A and B.
When used in conjunction with a two-step testing programme, C. Diff Quik Chek and Tox A/B Quik Chek can identify the presence of GDH and then differentiate between toxigenic and non-toxigenic C. difficile strains. First screening the samples with C. Diff Quik Chek will eliminate unnecessary toxin testing because 80 percent of the samples will be negative, ultimately saving money and time. Toxin detection using Tox A/B Quik Chek EK is performed on GDH positive samples for confirmation of the presence of C difficile toxin(s).

Both tests from Inverness Medical are rapid and easy-to-use with results in less than 30 minutes. The Techlab tests enable quicker turnaround of results compared to bacterial culture and cytotoxicity testing. Rapid diagnosis and treatment prevents spread of infection and can help save lives and reduce the cost burden on the health service. Faster isolation of infectious patients will reduce hospital outbreaks thereby leading to fewer hospital/ward closures.

The C. Diff Quik Chek and Tox A/B Quik Chek tests also detect the new hypervirulent strain of C difficile, associated with increased severity and high relapse rate. The new strain is more resistant to antibiotics, and is causing outbreaks of increased severity in North America and Europe.

Inverness Medical and Techlab continue to be at the forefront of C difficile research and are experts in the field of enteric diagnostics. Inverness Medical is also able to offer a wide range of testing formats for the detection of C difficile antigen glutamate dehydrogenase and Toxins A and B that can suit all laboratory practice and preference.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo